| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0087 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |